Cervical Cancer Screening, Screening Errors and Reporting

Schneider, Volker

doi:10.1159/000327853

Cited by 19 publications

(11 citation statements)

References 25 publications

(23 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[2][3][4] Half of the cases of cervical cancer in countries with screening coverage above 85% occur in women who were not tested over the previous 5 years, and among those tested, 12-23% did not have regular follow-up. 5 Although there is no ideal marker for cervical lesions, its characteristics should be to provide high sensitivity, not depend on subjective criteria for the diagnosis, be reasonable and affordable and especially be presented on easily collectable samples.…”

mentioning

confidence: 99%

Antibody Anti-p16INK4a in Cervical Cytology

Rocha

Bozzetti²,

Kirschnick³

et al. 2009

Acta Cytologica

View full text Add to dashboard Cite

mentioning

confidence: 99%

Antibody Anti-p16INK4a in Cervical Cytology

Rocha

Bozzetti²,

Kirschnick³

et al. 2009

Acta Cytologica

View full text Add to dashboard Cite

“…Liquid base cytology reduces the number of inadequate smears requiring patient call back for rescreening but is expensive. [13] TBS (The Bethesda System) of interpretation of Pap smear is practiced by most of the centers. The squamous cellular abnormalities described in TBS are as ASC, LSIL, HSIL & Squamous cell carcinoma.…”

Section: Discussionmentioning

confidence: 99%

Cervical cytology in women with abnormal cervix.

Rahatgaonkar¹

2012

iosrphr

View full text Add to dashboard Cite

Objectives: -To study cervical cytology in women with abnormal cervical findings on visual inspection. Methods:-Descriptive analytical study was conducted in Department of Gynecology & Obstetrics, Bharati Vidyapeeth Medical College, Pune, India.1600 women from Gynecology OPD having abnormal cervical findings on visual inspection were included in study. These women were subjected for Pap smear. Results: -Inflammatory changes were seen in 47.75% and precancerous lesions seen in 9.56% patients. Out of which LSIL was seen in 6.75% and HSIL was (CIN II & CIN III) in 2.81% of patients. In present study mean age for CIN was 38.13 ± 9.03 years. Malignant lesions were detected in 0.56% of patients, maximum in age group 41-45 years. Conclusion: -Women with abnormal cervical findings on visual inspection should be subjected to Pap smear to detect the disease in precancerous stage & to lower the mortality & morbidity.

show abstract

“…QA in cervical cytology was exhaustively discussed at the March 2000 International Consensus Conference on the Fight against Cervical Cancer (Chicago, Ill., USA). This conference was jointly sponsored by the International Academy of Cytology and several national and international organizations; it dealt with QA and error-risk reduction guidelines were addressed as a priority [51]. Since then, measures to improve the quality of the entire screening process have been indicated as being indispensable, and initiatives in this direction have been encouraged.…”

Section: Personnel Training and Certificationmentioning

confidence: 99%

“…Procedure/policy manuals, workload assessment, hierarchic/peer review, discrepancy analysis, rescreening studies and cytohistological correlation were considered examples of universally applicable quality tools. Strong management commitment and quality organization were stressed as necessary for the implementation of quality measures [51]. The commitment represented by management leadership and the delegation of CQI activities to competent staff, linkage with positive feedback and an interest in auditing and improving the system were clearly indicated.…”

Section: Personnel Training and Certificationmentioning

confidence: 99%

Recommendations on Quality Control and Quality Assurance in Cervical Cytology

Branca

Longatto‐Filho²

2015

Acta Cytologica

View full text Add to dashboard Cite

Objective: We aimed to critically evaluate the importance of quality control (QC) and quality assurance (QA) strategies in the routine work of uterine cervix cytology. Study Design: We revised all the main principles of QC and QA that are already being implemented worldwide and then discussed the positive aspects and limitations of these as well as proposing alternatives when pertinent. Results: A literature review was introduced after highlighting the main historical revisions, and then a critical evaluation of the principal innovations in screening programmes was conducted, with recommendations being postulated. Conclusions: Based on the analysed data, QC and QA are two essential arms that support the quality of a screening programme.

show abstract

Cervical Cancer Screening, Screening Errors and Reporting

Cited by 19 publications

References 25 publications

Antibody Anti-p16INK4a in Cervical Cytology

Antibody Anti-p16INK4a in Cervical Cytology

Cervical cytology in women with abnormal cervix.

Recommendations on Quality Control and Quality Assurance in Cervical Cytology

Contact Info

Product

Resources

About